{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:26:44Z","timestamp":1740162404036,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["Clinical Leave Stipend"],"award-info":[{"award-number":["Clinical Leave Stipend"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11096-019-00939-8","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T02:02:41Z","timestamp":1574301761000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hemodynamic changes in surgical intensive care unit patients undergoing echinocandin treatment"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2655-7363","authenticated-orcid":false,"given":"Christian","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Schneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Arens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Markmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Lichtenstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00134-017-4731-2","volume":"43","author":"M Bassetti","year":"2017","unstructured":"Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intens Care Med. 2017;43:1225\u201338.","journal-title":"Intens Care Med"},{"issue":"4","key":"939_CR2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0891-5520(20)30753-4","volume":"5","author":"MA Martin","year":"1991","unstructured":"Martin MA. Epidemiology and clinical impact of gram-negative sepsis. Infect Dis Clin North Am. 1991;5(4):739\u201352.","journal-title":"Infect Dis Clin North Am"},{"key":"939_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309\u201317.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"939_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19\u201337.","journal-title":"Clin Microbiol Infect"},{"key":"939_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62:e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63:e1\u201360.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"939_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10096-014-2287-4","volume":"34","author":"J-F Wang","year":"2015","unstructured":"Wang J-F, Xue Y, Zhu X-B, Fan H. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs. Eur J Clin Microbiol Infect Dis. 2015;34(4):651\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"939_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1586\/14787210.2015.1028366","volume":"13","author":"EW Muilwijk","year":"2015","unstructured":"Muilwijk EW, Lempers VJ, Burger DM, Warris A, Pickkers P, Aarnoutse RE, et al. Impact of special patient populations on the pharmacokinetics of echinocandins. Expert Rev Anti Infect Ther. 2015;13(6):799\u2013815.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jcpt.12078","volume":"38","author":"C Lichtenstern","year":"2013","unstructured":"Lichtenstern C, Wolff M, Arens C, Klie F, Majeed RW, Henrich M, et al. Cardiac effects of echinocandin preparations\u2014three case reports. J Clin Pharm Ther. 2013;38:429\u201331.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"939_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/jcpt.12046","volume":"38","author":"M Fink","year":"2013","unstructured":"Fink M, Zerlauth U, Kaulfersch C, Rab A, Alberer D, Preiss P, et al. A severe case of haemodynamic instability during anidulafungin administration. J Clin Pharm Ther. 2013;38(3):241\u20132.","journal-title":"J Clin Pharm Ther"},{"key":"939_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1365-2710.2011.01309.x","volume":"37","author":"CB Hindahl","year":"2012","unstructured":"Hindahl CB, Wilson JW. Flash pulmonary oedema during anidulafungin administration. J Clin Pharm Ther. 2012;37:491\u20133.","journal-title":"J Clin Pharm Ther"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s15010-015-0828-0","volume":"43","author":"T Lahmer","year":"2015","unstructured":"Lahmer T, Schnappauf C, Messer M, Rasch S, Fekecs L, Beitz A, et al. Influence of echinocandin administration on hemodynamic parameters in medical intensive care unit patients: a single center prospective study. Infection. 2015;43:723\u20137.","journal-title":"Infection"},{"issue":"1","key":"939_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1517\/14740338.2013.829036","volume":"13","author":"KR Stover","year":"2014","unstructured":"Stover KR, Farley JM, Kyle PB, Cleary JD. Cardiac toxicity of some echinocandin antifungals. Expert Opin Drug Saf. 2014;13(1):5\u201314.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"939_CR14","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1128\/AAC.04446-14","volume":"59","author":"C Koch","year":"2015","unstructured":"Koch C, Uhle F, Wolff M, Arens C, Schulte A, Li L, et al. Cardiac effects of echinocandins after central venous administration in adult rats. Antimicrob Agents Chemother. 2015;59(3):1612\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"939_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/jphp.12429","volume":"67","author":"KR Stover","year":"2015","unstructured":"Stover KR, Cleary JD. Cardiac response to centrally administered echinocandin antifungals. J Pharm Pharmacol. 2015;67(9):1279\u201383.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"939_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00101-014-2289-8","volume":"63","author":"C Arens","year":"2014","unstructured":"Arens C, Uhle F, Wolff M, R\u00f6hrig R, Koch C, Schulte A, et al. Effects of echinocandin preparations on adult rat ventricular cardiomyocytes. Preliminary results of an in vitro study. Anaesthesist. 2014;63(2):129\u201334.","journal-title":"Anaesthesist"},{"issue":"3","key":"939_CR17","first-page":"132","volume":"8","author":"KR Stover","year":"2017","unstructured":"Stover KR, Cleary JD. Cardiac safety of high-dose micafungin. J Pharmacol Pharmacother. 2017;8(3):132\u20133.","journal-title":"J Pharmacol Pharmacother"},{"issue":"14","key":"939_CR18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/jama.2017.14172","volume":"318","author":"E Futier","year":"2017","unstructured":"Futier E, Lefrant J-Y, Guinot P-G, Godet T, Lorne E, Cuvillon P, Bertran S, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery. JAMA. 2017;318(14):1346\u201357.","journal-title":"JAMA"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/ALN.0000000000001432","volume":"126","author":"V Salmasi","year":"2017","unstructured":"Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery. Anesthesiology. 2017;126:47\u201365.","journal-title":"Anesthesiology"},{"issue":"Suppl 2","key":"939_CR20","first-page":"ii22","volume":"22","author":"J Kooman","year":"2007","unstructured":"Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, et al. EBPG guideline on haemodynamic instability. Nephrol Dial Transplant. 2007;22(Suppl 2):ii22\u201344.","journal-title":"Nephrol Dial Transplant"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/CCM.0000000000003763","volume":"47","author":"AK Khanna","year":"2019","unstructured":"Khanna AK, Maheshwari K, Mao G, Liu L, Perez-Protto SE, Chodavarapu P, Schacham YN, Sessler DI. Association between mean arterial pressure and acute kidney injury and a composite of myocardial injury and mortality in postoperative critically Ill patients. Crit Care Med. 2019;47:910\u20137.","journal-title":"Crit Care Med"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1128\/AAC.01766-15","volume":"60","author":"C Koch","year":"2016","unstructured":"Koch C, Wolff M, Henrich M, Weigand MA, Lichtenstern C, Uhle F. Cardiac effects of echinocandins in endotoxemic rats. Antimicrob Agents Chemother. 2016;60:301\u20136. https:\/\/doi.org\/10.1128\/AAC.01766-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 6","key":"939_CR23","doi-asserted-by":"publisher","first-page":"S662","DOI":"10.1093\/cid\/civ739","volume":"61","author":"JD Cleary","year":"2015","unstructured":"Cleary JD, Stover KR. Antifungal-associated drug-induced cardiac disease. Clin Infect Dis. 2015;61(Suppl 6):S662\u20138.","journal-title":"Clin Infect Dis"},{"key":"939_CR24","unstructured":"Shirey K, Stover KR, Cleary JD. Echinocandin antifungals\u2014inhibit and stimulate mitochondrial electron transfer. In: Intersience Conference On Antimicrobial Agents and Chemotherapy. Annual Meeting. Abstract; 2014."},{"issue":"4","key":"939_CR25","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1164\/ajrccm.160.4.9808149","volume":"160","author":"N Abi-Gerges","year":"1999","unstructured":"Abi-Gerges N, Tavernier B, Mebazaa A, Faivre V, Paqueron X, Payen D, et al. Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat. Am J Respir Crit Care Med. 1999;160(4):1196\u2013204.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"939_CR26","first-page":"H2312","volume":"273","author":"J Zhong","year":"1997","unstructured":"Zhong J, Hwang TC, Adams HR, Rubin LJ. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol. 1997;273(5):H2312\u201324.","journal-title":"Am J Physiol"},{"issue":"11","key":"939_CR27","doi-asserted-by":"publisher","first-page":"e01114","DOI":"10.1128\/AAC.01114-18","volume":"62","author":"C Koch","year":"2018","unstructured":"Koch C, Jersch J, Schneck E, Edinger F, Maxeiner H, Uhle F, Weigand MA, Markmann M, Sander M, Henrich M. Caspofungin modulates ryanodine receptor-mediated calcium release in human cardiac myocytes. Antimicrob Agents Chemother. 2018;62(11):e01114\u20138.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00939-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T15:01:08Z","timestamp":1665068468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00939-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00939-8","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CK received congress travel sponsorship from Pfizer and advisory board fees from Astellas Pharma. ES, CA and MM have no deflect to declare. MS received grants from Masimo, Ratiopharm, Edwards Lifesciences, Getinge Group, AMOMED and Medtronic. MAW received speaker fees and advisory fees from Astellas Pharma, MSD Sharp & Dohme, Pfizer Pharma, Novartis, Janssen, Gilead, Bayer, Astra Zeneca, Glaxo Smith Kline, Braun, Biosyn, Eli Lilly, ZLB Behring, K\u00f6hler Chemie. CL received speaker fees and advisory fees from Astellas Pharma, Basilea Pharmaceutica, MSD Sharp & Dohme, and Pfizer Pharma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}